ANGN logo

Angion Biomedica (ANGN) Cash From Financing

ANGN Annual CFF

-$60.00 K
-$107.23 M-100.06%

31 December 2022

ANGN Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANGN Quarterly CFF

-$3.27 M
-$3.25 M-21686.67%

31 March 2023

ANGN Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANGN TTM CFF

-$3.31 M
-$3.25 M-5423.33%

31 March 2023

ANGN TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ANGN Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.1%-10000.0%-157.5%
3 y3 years-101.2%-183.0%-184.2%
5 y5 years-100.2%--

ANGN Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-100.1%-103.0%-102.1%

Angion Biomedica Cash From Financing History

DateAnnualQuarterlyTTM
Mar 2023
-
-$3.27 M(>+9900.0%)
-$3.31 M(+5423.3%)
Dec 2022
-$60.00 K(-100.1%)
-$15.00 K(-11.8%)
-$60.00 K(-116.7%)
Sept 2022
-
-$17.00 K(+21.4%)
$359.00 K(-66.6%)
June 2022
-
-$14.00 K(0.0%)
$1.07 M(-183.5%)
Mar 2022
-
-$14.00 K(-103.5%)
-$1.29 M(-101.2%)
Dec 2021
$107.17 M(+104.5%)
$404.00 K(-42.2%)
$107.17 M(+0.2%)
Sept 2021
-
$699.00 K(-129.4%)
$106.97 M(-22.2%)
June 2021
-
-$2.38 M(-102.2%)
$137.49 M(-12.4%)
Mar 2021
-
$108.44 M(>+9900.0%)
$156.92 M(+199.4%)
Dec 2020
$52.41 M
$202.00 K(-99.4%)
$52.41 M(+0.4%)
DateAnnualQuarterlyTTM
Sept 2020
-
$31.22 M(+83.0%)
$52.21 M(+148.7%)
June 2020
-
$17.05 M(+333.3%)
$20.99 M(+433.3%)
Mar 2020
-
$3.94 M(-639.3%)
$3.94 M(-550.4%)
Dec 2019
$4.89 M(-84.6%)
-
-
Dec 2018
$31.74 M(-2808.3%)
-
-
June 2014
-
-$729.80 K(+406.5%)
-$873.90 K(+272.2%)
Mar 2014
-
-$144.10 K(+58.9%)
-$234.80 K(-36.4%)
Dec 2013
-$1.17 M(+173.1%)
-
-
June 2013
-
-$90.70 K(-67.5%)
-$369.40 K(+32.5%)
Mar 2013
-
-$278.70 K
-$278.70 K
Dec 2012
-$429.20 K
-
-

FAQ

  • What is Angion Biomedica annual cash flow from financing activities?
  • What is the all time high annual CFF for Angion Biomedica?
  • What is Angion Biomedica annual CFF year-on-year change?
  • What is Angion Biomedica quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Angion Biomedica?
  • What is Angion Biomedica quarterly CFF year-on-year change?
  • What is Angion Biomedica TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Angion Biomedica?
  • What is Angion Biomedica TTM CFF year-on-year change?

What is Angion Biomedica annual cash flow from financing activities?

The current annual CFF of ANGN is -$60.00 K

What is the all time high annual CFF for Angion Biomedica?

Angion Biomedica all-time high annual cash flow from financing activities is $107.17 M

What is Angion Biomedica annual CFF year-on-year change?

Over the past year, ANGN annual cash flow from financing activities has changed by -$107.23 M (-100.06%)

What is Angion Biomedica quarterly cash flow from financing activities?

The current quarterly CFF of ANGN is -$3.27 M

What is the all time high quarterly CFF for Angion Biomedica?

Angion Biomedica all-time high quarterly cash flow from financing activities is $108.44 M

What is Angion Biomedica quarterly CFF year-on-year change?

Over the past year, ANGN quarterly cash flow from financing activities has changed by -$3.25 M (-23242.86%)

What is Angion Biomedica TTM cash flow from financing activities?

The current TTM CFF of ANGN is -$3.31 M

What is the all time high TTM CFF for Angion Biomedica?

Angion Biomedica all-time high TTM cash flow from financing activities is $156.92 M

What is Angion Biomedica TTM CFF year-on-year change?

Over the past year, ANGN TTM cash flow from financing activities has changed by -$2.03 M (-157.50%)